Rifampicin in Osteoarticular Infections: A Comprehensive Review of Current Evidence
Abstract
Background: Osteoarticular infections (OAI)-including prosthetic joint infections (PJI), fracture-related infections (FRI), and osteomyelitis-are challenging to cure because bacterial biofilm on implant surfaces confers up to 1000-fold antibiotic tolerance, driving chronicity and relapse. Rifampicin, through its bactericidal activity against quiescent, biofilm-embedded bacteria and excellent oral bioavailability, occupies a pivotal role in managing Gram-positive OAI.
Methods: This comprehensive narrative review synthesises mechanistic, preclinical, and clinical evidence on rifampicin across the three major osteoarticular infection types and by causative pathogen. PubMed/MEDLINE, Embase, Scopus, and the Cochrane Library were searched (January 1990-June 2026); of several hundred candidate records identified, the 101 most relevant were selected for narrative synthesis.
Results: The strongest evidence supports rifampicin in staphylococcal PJI managed with debridement, antibiotics, and implant retention (DAIR), with fluoroquinolones as optimal companions; monotherapy invariably selects resistant mutants. This benefit is expected to extend beyond PJI to other osteoarticular infections managed with hardware retention-fracture-related infection and implant-associated osteomyelitis-given the shared biofilm target on retained metalwork. Benefit is attenuated in implant-exchange procedures, and evidence for streptococci, Cutibacterium acnes, and enterococci remains insufficient for…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.